GW406108X

GW406108X is an inhibitor of Kinesins used in studies of PI3K-Akt-mTOR Signaling and Cell Cycle Regulation and related signaling programs. In practice, this places the compound in experiments that measure growth-factor signaling, survival control, and nutrient-sensing outputs and checkpoint control, mitotic progression, and proliferation timing in autophagy, cancer, and cell cycle models.

By inhibiting Kinesins, GW406108X can be used to examine growth-factor signaling, survival control, and nutrient-sensing outputs and checkpoint control, mitotic progression, and proliferation timing. This context is compatible with AKT/mTOR readouts, pathway-response, and viability assays and cell-cycle, mitotic, and proliferation assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In autophagy, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Kinesins
• Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling and Cell Cycle Regulation and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Phenotypic profiling in autophagy, cancer, and cell cycle models

Overall, GW406108X is appropriate when a defined chemical perturbant is needed to connect Kinesins with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in autophagy, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.